Skip to main content
Oriola Oyj logo

Oriola Oyj — Investor Relations & Filings

Ticker · OKDAV ISIN · FI0009014344 LEI · 549300UWB1AIR85BM957 HE Wholesale and retail trade
Open in API
Filings indexed 1,782 across all filing types
Latest filing 2022-07-22 Report Publication Anno…
Country FI Finland
Listing HE OKDAV

About Oriola Oyj

https://www.oriola.com/

Oriola is a health and wellbeing company providing pharmaceutical distribution, wholesale, and advisory services in the Nordic market. The company connects pharmaceutical companies and health product suppliers with pharmacies, healthcare providers, veterinarians, and retailers. Core services include GDP-compliant supply chain management, warehousing, and specialized logistics like cold chain and vaccine distribution. The wholesale business offers a broad product range and leverages deep market knowledge to facilitate market access. Advisory services support clients throughout the product lifecycle with expertise in market entry, regulatory compliance, and commercial strategy, ensuring operational efficiency and customer value.

Recent filings

Filing Released Lang Actions
Oriola Corporation's Half Year Financial Report 1 January - 30 June 2022
Report Publication Announcement Classification · 95% confidence The document is a stock exchange release from Oriola Corporation announcing their 'Half Year Financial Report'. While it contains summary financial data, the text explicitly states: 'This stock exchange release is a summary of Oriola Corporation's Half Year Financial Report January-June 2022. The complete report is attached to this release in pdf format'. Following the 'Menu vs Meal' rule, since this is an announcement of a report that is attached separately, it is classified as a Report Publication Announcement (RPA).
2022-07-22 English
Muutos Oriolan johtoryhmässä
Board/Management Information Classification · 100% confidence The document is a press release titled 'Muutos Oriolan johtoryhmässä' (Change in Oriola's Management Team). It announces the appointment of a new Chief Financial Officer (CFO) and provides biographical details (CV) of the appointee. This falls directly under the category of announcements regarding changes in senior management.
2022-07-19 Finnish
Muutos Oriolan johtoryhmässä
Board/Management Information Classification · 100% confidence The document text explicitly announces a 'Muutos Oriolan johtoryhmässä' (Change in Oriola's management team) and details the appointment of KTM Timo Leinonen as the new CFO and a member of the management group. This directly corresponds to the definition of Board/Management Information.
2022-07-19 Finnish
Change in Oriola Management Team
Board/Management Information Classification · 100% confidence The document is a 'Stock Exchange Release' from Oriola Corporation announcing a 'Change in Oriola Management Team'. Specifically, it details the appointment of a new Chief Financial Officer (CFO), Timo Leinonen, including his start date and professional background (CV). This content directly matches the definition for Board/Management Information.
2022-07-19 English
Ruotsin kilpailuviranomainen on hyväksynyt Oriolan ja Euroapothecan apteekkitoimintojen yhdistymisen
M&A Activity Classification · 100% confidence The document is a press release announcing that the Swedish Competition Authority has approved the merger between Oriola and Euroapotheca's pharmacy operations. Since this document details a merger proposal and its regulatory approval status, it falls under the category of M&A activity.
2022-06-30 Finnish
Ruotsin kilpailuviranomainen on hyväksynyt Oriolan ja Euroapothecan apteekkitoimintojen yhdistymisen
Regulatory Filings Classification · 100% confidence The document is a short press release (1636 chars) from Oriola Oyj, dated June 30, 2022, announcing that the Swedish Competition Authority (Konkurrensverket) has approved the merger of Oriola's pharmacy operations (Kronans Apotek) with Euroapotheca's pharmacy operations. This concerns a significant corporate transaction (merger/acquisition) and is being released as a regulatory disclosure ('pörssitiedote'). Since it is an announcement about a major corporate event (M&A activity) rather than the final detailed legal filing (like a 10-K or a full legal report), it fits best under the M&A Activity category (TAR). It is not a general regulatory filing (RNS) because TAR is more specific. It is not an RPA because it is announcing the *completion* of an approval phase for a transaction, not the publication of a financial report.
2022-06-30 Finnish

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.